Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - canine distemper virus strain n-cdv (live, attenuated); canine adenovirus type 2 virus, strain manhattan (live, attenuated); canine parainfluenza type 5 virus, strain nl-cpi-5 (live, attenuated); canine parvovirus strain nl-35-d (live, attenuated); leptospira canicola inactivated ; leptospira icterohaemorrhagiae inactivated - lyophilisate and solvent for solution for injection - . - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira - dogs - immunological - mixed vaccine (l & a)

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - canine distemper virus strain n-cdv (live, attenuated), canine adenovirus type 2 virus, strain manhattan (live, attenuated), canine parainfluenza type 5 virus, strain nl-cpi-5 (live, attenuated), canine parvovirus, strain nl-35-d, live attenuated, leptospira icterohaemorrhagiae inactivated, leptospira canicola inactivated - lyophilisate and solvent for solution for injection - %v/v - live canine distemper virus vaccine + live canine adenovirus vaccine + live canine parainfluenza vi - canine - immunological - mixed vaccine (live and inactivated)

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parainfluenza type 2; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parainfluenza type 2 vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 2 | canine distemper | canine parainfluenza | canine parvovirus | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - canine adeno virus type 2; canine distemper virus; canine parvo virus - misc. vaccines or anti sera - canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus vaccine-viral active 0.0 p; canine parvo virus vaccine-viral active 0.0 p - immunotherapy - dog - over 6 weeks old - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine adenovirus type 2 strain manhattan - live; canine distemper virus strain onderstepoort; canine parvovirus strain 154 - live - parenteral liquid/solution/suspension - canine adenovirus type 2 strain manhattan - live vaccine-viral active 0.0 tcid50; canine distemper virus strain onderstepoort vaccine-viral active 0.0 tcid50; canine parvovirus strain 154 - live vaccine-viral active 0.0 tcid50 - immunotherapy - dog - with exclusions see label - canine adenovirus - type 1 | canine adenovirus - type 2 | canine distemper | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | infectious canine hepatitis | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - canine distemper virus - living; canine adenovirus type 2 - live (infectious hepatitis); canine parvovirus - live - misc. vaccines or anti sera - canine distemper virus - living vaccine-viral active 0.0 p; canine adenovirus type 2 - live (infectious hepatitis) vaccine-viral active 0.0 p; canine parvovirus - live vaccine-viral active 0.0 p - immunotherapy - dog | bitch | castrate | puppy - canine distemper | canine parvovirus | hepatitis :- infectious | vaccine | canine adenovirus type 1 | canine adenovirus type 2 | equine rotavirus | infectious canine hepatitis | parvovirus

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - canine parvovirus (inactivated); thiomersal - parenteral liquid/solution/suspension - canine parvovirus (inactivated) vaccine-viral active 0.0 u; thiomersal mercury other 0.1 mg/ml - immunotherapy - dog | bitch | castrate | puppy - canine parvovirus | parvovirus

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live canine parainfluenza virus + live canine parvovirus + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 6 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae and to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa.

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - canine distemper virus, strain cdv bio 11/a, canine adenovirus type 2, strain cav-2 bio 13, canine parvovirus type 2b, strain cpv-2b bio 12/b, canine parainfluenza type 2 virus, strain cpiv-2 bio 15 (all live attenuated), leptospira interrogans serogroup australis serovar bratislava, strain mslb 1088, l. interrogans serogroup icterohaemorrhagiae serovar icterohaemorrhagiae, strain mslb 1089, l. interrogans serogroup canicola serovar canicola, strain mslb 1090, l. kirschneri serogroup grippotyphosa serovar grippotyphosa, strain mslb 1091... - live canine distemper virus + live canine adenovirus + live parainfl.virus + live canine parvovirus + inactivated rabies + inactivated leptospira, immunologicals for canidae - dogs - active immunisation of dogs from 8–9 weeks of age:to prevent mortality and clinical signs caused by canine distemper virus,to prevent mortality and clinical signs caused by canine adenovirus type 1,to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2,to prevent clinical signs, leucopoenia and viral excretion caused by canine parvovirus,to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus,to prevent clinical signs, infection and urinary excretion caused by l. interrogans serogroup australis serovar bratislava,to prevent clinical signs and urinary excretion and reduce infection caused by l. interrogans serogroup canicola serovar canicola and l. interrogans serogroup icterohaemorrhagie serovar icterohaemorrhagiae,to prevent clinical signs and reduce infection and urinary excretion caused by l. interrogans serogroup grippotyphosa serovar grippotyphosa and to prevent mortality, clinical signs and infection caused by rabies virus.

Ireland - English - HPRA (Health Products Regulatory Authority)

zoetis belgium s.a. - live canine parvovirus strain nl-35-d - solution for injection - . - canine parvovirus - dogs - immunological - live vaccine